RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172934

FDA DEVICE FACTS

Needle Free Transseptal Cannula

Pressure Products Medical Device Manufacturing, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 16, 2018PRODUCT CODEDRC

Indications for use

The Transseptal Cannula is used in conjunction with a transseptal guidewire to puncture the interatrial septum during a transseptal catheterization procedure to gain left heart access. The Transseptal Cannula is intended for single use only.

The BRK Transseptal Needle is used to puncture the interatrial septum during a transseptal catheterization procedure to gain left heart access.

Both the Transseptal Cannula and the transseptal needle are used in transseptal catheterization procedures to gain left heart access. The difference between the two indications for use is that the Transseptal Cannula is used with a transseptal guidewire to puncture the septum, while the transseptal needle has a needle point and it is used on its own to puncture the septum. Because the two devices are made of stainless steel, the Transseptal Cannula, when used in conjunction with a transseptal guidewire, mimics the same structural support as a procedure with the transseptal needle. Because of these similarities, the BRK transseptal needle is the predicate device for the Transseptal Cannula.

Comparison of Technological Characteristics with the Predicate Device The technological characteristics of this device are similar to the predicate device. The difference between the two indications for use is that the Transseptal Cannula is used with a transseptal guidewire to puncture the septum, while the transseptal needle has a needle point and it is used on its own to puncture the septum. The subject and predicate device are based on the follow technological elements:

• Stainless steel that provides structural support in the transseptal procedure

• Smooth inner diameter so devices can pass through the body of the devices smoothly

• Devices are inserted through the transseptal dilator and sheath assembly so that it can be used in the transseptal procedure

• Devices come in 71, 89, and 98cm lengths (actual lengths: 69.7cm, 87.7cm, and 96.7cm)

• Devices come in two curves, Curve0 and Curve1

• Devices assembled through the transseptal introducer system match curve shapes

• Cannula used with transseptal guidewire in the introducer assembly feels equivalent to the transseptal needle with the introducer assembly

The following are technological modifications to the predicate device:

• Needle point on predicate device to create the primary puncture of the fossa while Transseptal Cannula is used with a transseptal guidewire to create the primary puncture of the fossa

• The tip of the cannula is a blunt radius edge so it is stopped in the transseptal dilator while transseptal needle has a needle point

• Hub is clear instead of metal so that it is lighter and allows visualization of the introduction of devices

• Transseptal Cannula is a non-skiving device when inserted into the transseptal dilator

Performance Testing The following performance data were provided in support of the substantial equivalence to the predicate:

• Visual and dimensional inspection

• Particulate testing (USP<788>, Light Obscuration Method)

• Mating Joint Pull test (Handle to Hub)

• Guidewire Restriction Inspection

• Strength of Union Cannula Hub and Cannula

• Needle Point Inspection

• Hub Female Luer Taper

• Water Leak Testing

• Air Leak Testing

• Packaging Testing

Biocompatibility Data The biocompatibility evaluation for the Transseptal Cannula was conducted in accordance with FDA 510(k) Memorandum- #G95-1 “Use of International Standard ISO-10993, ‘Biological Evaluation of Medical Devices Part 1: Evaluation and Testing,’” June 16, 2016, and International Standard ISO 10993-1 “Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing Within a Risk Management Process,” as recognized by the FDA. The following tests were performed:

• ISO 10993-5 Cytotoxicity

• ISO 10993-10 Sensitization

• ISO 10993-10 Irritation/Intracutaneous Reactivity

• ISO 10993-11 Acute Systemic Toxicity

• ISO 10993-11 Pyrogenicity

• ISO 10993-3 Genotoxicity

• ISO 10993-4 Hemocompatibility – ASTM Hemolysis Complete

• ISO 10993-4 Hemocompatibility – Complement Activation Complete with C3a & SC5b-9

The Needle FreeTM Transseptal Cannula is considered an external communicating device with an indirect blood path, and limited exposure (less than 24 hours). The Transseptal Cannula met the requirements set forth in ISO-10993.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026